Brain Diseases  >>  lisdexamfetamine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lisdexamfetamine / Generic mfg.
NCT01000064: Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits

Terminated
3
22
US
Vyvanse, fMRI, functional magnetic resonance imaging, Placebo
Vanderbilt University, Shire
Traumatic Brain Injury, Attention Deficit Disorder
12/13
05/15

Download Options